hu.MAP 3.0: Complex View
Human Protein Complex Map
Search for a protein
Complex: huMAP3_01026.1
Complex Portal: CPX-15641
Confidence: Extremely High  
Proteins| Genename | Protein Name | Uniprot Annotation Score | Links |
|---|---|---|---|
| CKS2 | Cyclin-dependent kinases regulatory subunit 2 (CKS-2) | 4 | UniProt   NCBI |
| EP300 | Histone acetyltransferase p300 (p300 HAT) (EC 2.3.1.48) (E1A-associated protein p300) (Histone butyryltransferase p300) (EC 2.3.1.-) (Histone crotonyltransferase p300) (EC 2.3.1.-) (Protein 2-hydroxyisobutyryltransferase p300) (EC 2.3.1.-) (Protein lactyltransferas p300) (EC 2.3.1.-) (Protein propionyltransferase p300) (EC 2.3.1.-) | 5 | UniProt   NCBI |
| MIDEAS | Mitotic deacetylase-associated SANT domain protein (ELM2 and SANT domain-containing protein 1) | 4 | UniProt   NCBI |
| SKP2 | S-phase kinase-associated protein 2 (Cyclin-A/CDK2-associated protein p45) (F-box protein Skp2) (F-box/LRR-repeat protein 1) (p45skp2) | 5 | UniProt   NCBI |
| CDT1 | DNA replication factor Cdt1 (Double parked homolog) (DUP) | 5 | UniProt   NCBI |
| SCAPER | S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291) | 5 | UniProt   NCBI |
| CREBBP | CREB-binding protein (Histone lysine acetyltransferase CREBBP) (EC 2.3.1.48) (Protein-lysine acetyltransferase CREBBP) (EC 2.3.1.-) | 5 | UniProt   NCBI |
| CCNA2 | Cyclin-A2 (Cyclin-A) (Cyclin A) | 5 | UniProt   NCBI |
| CCNA1 | Cyclin-A1 | 5 | UniProt   NCBI |
Enrichments
| Term ID | Corrected Pval | Fraction Complex Coverage | Proteins | Term Name |
|---|---|---|---|---|
|   KEGG:04110 | 1.50046284793e-09 | 0.75 | EP300 CDT1 CCNA2 CREBBP SKP2 CCNA1 | Cell cycle |
|   KEGG:05203 | 8.50446741154e-07 | 0.625 | CCNA1 EP300 CREBBP CCNA2 SKP2 | Viral carcinogenesis |
|   REAC:R-HSA-68949 | 7.08314138735e-06 | 0.5 | SKP2 CCNA2 CCNA1 CDT1 | Orc1 removal from chromatin |
|   REAC:R-HSA-69052 | 1.96526025984e-05 | 0.5 | SKP2 CCNA2 CCNA1 CDT1 | Switching of origins to a post-replicative state |
|   WP:WP179 | 2.3481565781e-05 | 0.5 | EP300 CCNA2 CCNA1 SKP2 | Cell cycle |
|   KEGG:05161 | 3.39066033667e-05 | 0.5 | EP300 CREBBP CCNA1 CCNA2 | Hepatitis B |
|   REAC:R-HSA-69239 | 6.06857205648e-05 | 0.5 | SKP2 CCNA2 CCNA1 CDT1 | Synthesis of DNA |
|   KEGG:05200 | 6.65080913942e-05 | 0.625 | CCNA1 EP300 CREBBP CCNA2 SKP2 | Pathways in cancer |
|   CORUM:4 | 7.17483486175e-05 | 0.25 | EP300 CREBBP | Multisubunit ACTR coactivator complex |
|   CORUM:571 | 7.17483486175e-05 | 0.25 | EP300 CREBBP | p300-CBP-p270 complex |
|   REAC:R-HSA-69206 | 8.65980296911e-05 | 0.5 | SKP2 CCNA2 CCNA1 CDT1 | G1/S Transition |
|   KEGG:05166 | 0.000108545420387 | 0.5 | EP300 CREBBP CCNA1 CCNA2 | Human T-cell leukemia virus 1 infection |
|   REAC:R-HSA-453279 | 0.000141818979527 | 0.5 | SKP2 CCNA2 CCNA1 CDT1 | Mitotic G1 phase and G1/S transition |
|   REAC:R-HSA-170145 | 0.000167311042734 | 0.25 | CCNA2 CCNA1 | Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes |
|   REAC:R-HSA-69242 | 0.000194205912298 | 0.5 | SKP2 CCNA2 CCNA1 CDT1 | S Phase |
|   HP:0005895 | 0.000226027933833 | 0.25 | EP300 CREBBP | Radial deviation of thumb terminal phalanx |
|   HP:0008107 | 0.000226027933833 | 0.25 | EP300 CREBBP | Plantar crease between first and second toes |
|   HP:0034227 | 0.000226027933833 | 0.25 | EP300 CREBBP | Aortic isthmus hypoplasia |
|   HP:0001042 | 0.000226027933833 | 0.25 | EP300 CREBBP | High axial triradius |
|   CORUM:2638 | 0.000239030245992 | 0.25 | EP300 CREBBP | HES1 promoter corepressor complex |
|   REAC:R-HSA-69306 | 0.00027852607085 | 0.5 | SKP2 CCNA2 CCNA1 CDT1 | DNA Replication |
|   REAC:R-HSA-6791312 | 0.000321537118395 | 0.375 | EP300 CCNA1 CCNA2 | TP53 Regulates Transcription of Cell Cycle Genes |
|   CORUM:570 | 0.000501688733948 | 0.25 | EP300 CREBBP | p300-CBP-p270-SWI/SNF complex |
|   KEGG:05165 | 0.000521724713369 | 0.5 | EP300 CREBBP CCNA1 CCNA2 | Human papillomavirus infection |
|   REAC:R-HSA-68911 | 0.000557398190654 | 0.25 | CCNA2 CCNA1 | G2 Phase |
|   REAC:R-HSA-3134973 | 0.000557398190654 | 0.25 | EP300 CREBBP | LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production |
|   REAC:R-HSA-69278 | 0.000645311785686 | 0.625 | CDT1 EP300 CCNA2 CCNA1 SKP2 | Cell Cycle, Mitotic |
|   HP:0005322 | 0.000677898190386 | 0.25 | EP300 CREBBP | Prominent nasal septum |
|   HP:0005363 | 0.000677898190386 | 0.25 | EP300 CREBBP | Humoral immunodeficiency |
|   HP:0006200 | 0.000677898190386 | 0.25 | EP300 CREBBP | Widened distal phalanges |
|   HP:0008752 | 0.000677898190386 | 0.25 | EP300 CREBBP | Laryngeal cartilage malformation |
|   HP:5200232 | 0.000677898190386 | 0.25 | EP300 CREBBP | Phobia |
|   HP:0000756 | 0.000677898190386 | 0.25 | EP300 CREBBP | Agoraphobia |
|   REAC:R-HSA-187577 | 0.000772420116886 | 0.375 | SKP2 CCNA1 CCNA2 | SCF(Skp2)-mediated degradation of p27/p21 |
|   WP:WP2446 | 0.000984012141689 | 0.375 | SKP2 CCNA2 CDT1 | Retinoblastoma gene in cancer |
|   REAC:R-HSA-5688426 | 0.00116097595432 | 0.5 | EP300 CCNA2 CCNA1 SKP2 | Deubiquitination |
|   REAC:R-HSA-1234158 | 0.00116989543065 | 0.25 | EP300 CREBBP | Regulation of gene expression by Hypoxia-inducible Factor |
|   KEGG:04068 | 0.00121300286162 | 0.375 | EP300 CREBBP SKP2 | FoxO signaling pathway |
|   HP:0410266 | 0.00135542525381 | 0.25 | EP300 CREBBP | Visceral hemangioma |
|   HP:0031207 | 0.00135542525381 | 0.25 | EP300 CREBBP | Hepatic hemangioma |
|   HP:0010775 | 0.00135542525381 | 0.25 | EP300 CREBBP | Vascular ring |
|   HP:0011087 | 0.00135542525381 | 0.25 | EP300 CREBBP | Talon cusp |
|   HP:0001128 | 0.00135542525381 | 0.25 | EP300 CREBBP | Trichiasis |
|   REAC:R-HSA-9818028 | 0.00155943355885 | 0.25 | EP300 CREBBP | NFE2L2 regulates pentose phosphate pathway genes |
|   REAC:R-HSA-1640170 | 0.00178497530737 | 0.625 | CDT1 EP300 CCNA2 CCNA1 SKP2 | Cell Cycle |
|   REAC:R-HSA-69202 | 0.00198770799356 | 0.375 | SKP2 CCNA1 CCNA2 | Cyclin E associated events during G1/S transition |
|   REAC:R-HSA-69656 | 0.00213752571158 | 0.375 | SKP2 CCNA1 CCNA2 | Cyclin A:Cdk2-associated events at S phase entry |
|   HP:0009715 | 0.00225842370351 | 0.25 | EP300 CREBBP | Papillary cystadenoma of the epididymis |
|   HP:0030421 | 0.00225842370351 | 0.25 | EP300 CREBBP | Epididymal neoplasm |
|   HP:0033777 | 0.00225842370351 | 0.25 | EP300 CREBBP | Supernumerary cusp |
|   REAC:R-HSA-453276 | 0.0022946325687 | 0.375 | SKP2 CCNA1 CCNA2 | Regulation of mitotic cell cycle |
|   REAC:R-HSA-174143 | 0.0022946325687 | 0.375 | SKP2 CCNA1 CCNA2 | APC/C-mediated degradation of cell cycle proteins |
|   REAC:R-HSA-8866907 | 0.00250486048439 | 0.25 | EP300 CREBBP | Activation of the TFAP2 (AP-2) family of transcription factors |
|   REAC:R-HSA-9617629 | 0.00250486048439 | 0.25 | EP300 CREBBP | Regulation of FOXO transcriptional activity by acetylation |
|   WP:WP4673 | 0.0025453607788 | 0.375 | EP300 CREBBP CCNA1 | Male infertility |
|   REAC:R-HSA-210744 | 0.0030606580132 | 0.25 | EP300 CREBBP | Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells |
|   REAC:R-HSA-8941856 | 0.0030606580132 | 0.25 | EP300 CREBBP | RUNX3 regulates NOTCH signaling |
|   REAC:R-HSA-2262752 | 0.00307361160036 | 0.625 | CCNA1 EP300 CREBBP CCNA2 SKP2 | Cellular responses to stress |
|   REAC:R-HSA-8953897 | 0.00322172503192 | 0.625 | CCNA1 EP300 CREBBP CCNA2 SKP2 | Cellular responses to stimuli |
|   HP:0004411 | 0.00338670821406 | 0.25 | EP300 CREBBP | Deviated nasal septum |
|   HP:0100852 | 0.00338670821406 | 0.25 | EP300 CREBBP | Abnormal fear-induced behavior |
|   HP:0002700 | 0.00338670821406 | 0.25 | EP300 CREBBP | Large foramen magnum |
|   REAC:R-HSA-3700989 | 0.00388943076684 | 0.5 | EP300 CREBBP CCNA1 CCNA2 | Transcriptional Regulation by TP53 |
|   REAC:R-HSA-9755511 | 0.00406418842136 | 0.375 | EP300 CREBBP SKP2 | KEAP1-NFE2L2 pathway |
|   WP:WP3657 | 0.00407177869695 | 0.25 | EP300 CREBBP | Hematopoietic stem cell gene regulation by GABP alpha beta complex |
|   REAC:R-HSA-3371568 | 0.00433819320746 | 0.25 | EP300 CREBBP | Attenuation phase |
|   REAC:R-HSA-6804116 | 0.00433819320746 | 0.25 | CCNA2 CCNA1 | TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest |
|   HP:0011335 | 0.00474009355523 | 0.25 | EP300 CREBBP | Frontal hirsutism |
|   HP:0030434 | 0.00474009355523 | 0.25 | EP300 CREBBP | Pilomatrixoma |
|   HP:0003042 | 0.00478067755223 | 0.375 | EP300 CREBBP CDT1 | Elbow dislocation |
|   KEGG:05169 | 0.00486719923682 | 0.375 | SKP2 CCNA1 CCNA2 | Epstein-Barr virus infection |
|   REAC:R-HSA-918233 | 0.00505983974502 | 0.25 | EP300 CREBBP | TRAF3-dependent IRF activation pathway |
|   HP:0001956 | 0.00521241067413 | 0.375 | EP300 SCAPER CREBBP | Truncal obesity |
|   REAC:R-HSA-9013695 | 0.00583667819665 | 0.25 | EP300 CREBBP | NOTCH4 Intracellular Domain Regulates Transcription |
|   HP:0031251 | 0.0063183945919 | 0.25 | EP300 CREBBP | Abnormal subclavian artery morphology |
|   HP:0002341 | 0.0063183945919 | 0.25 | EP300 CREBBP | Cervical cord compression |
|   REAC:R-HSA-9818027 | 0.00666866305696 | 0.25 | EP300 CREBBP | NFE2L2 regulating anti-oxidant/detoxification enzymes |
|   REAC:R-HSA-9614657 | 0.00666866305696 | 0.25 | EP300 CREBBP | FOXO-mediated transcription of cell death genes |
|   REAC:R-HSA-1368082 | 0.00666866305696 | 0.25 | EP300 CREBBP | RORA activates gene expression |
|   HP:0030310 | 0.00692547687117 | 0.375 | EP300 CREBBP CDT1 | Upper extremity joint dislocation |
|   HP:0010314 | 0.00812142628406 | 0.25 | EP300 CREBBP | Premature thelarche |
|   REAC:R-HSA-9793380 | 0.00849789009901 | 0.25 | EP300 CREBBP | Formation of paraxial mesoderm |
|   WP:WP3414 | 0.00964105812378 | 0.25 | EP300 CREBBP | Initiation of transcription and translation elongation at the HIV 1 LTR |
|   HP:0002697 | 0.0101490036868 | 0.25 | EP300 CREBBP | Parietal foramina |
|   HP:0007086 | 0.0101490036868 | 0.25 | EP300 CREBBP | Social and occupational deterioration |
|   HP:0009714 | 0.0101490036868 | 0.25 | EP300 CREBBP | Abnormal epididymis morphology |
|   REAC:R-HSA-5621575 | 0.0105471572959 | 0.25 | EP300 CREBBP | CD209 (DC-SIGN) signaling |
|   REAC:R-HSA-9013508 | 0.0105471572959 | 0.25 | EP300 CREBBP | NOTCH3 Intracellular Domain Regulates Transcription |
|   WP:WP4241 | 0.0117685644016 | 0.25 | EP300 CREBBP | Type 2 papillary renal cell carcinoma |
|   HP:0003045 | 0.0121523513052 | 0.375 | EP300 CREBBP CDT1 | Abnormal patella morphology |
|   HP:0000278 | 0.0122351901604 | 0.5 | EP300 SCAPER CREBBP CDT1 | Retrognathia |
|   HP:0000321 | 0.0124009419501 | 0.25 | EP300 CREBBP | Square face |
|   HP:0010562 | 0.0124009419501 | 0.25 | EP300 CREBBP | Keloids |
|   HP:0000273 | 0.0124009419501 | 0.25 | EP300 CREBBP | Facial grimacing |
|   REAC:R-HSA-5633007 | 0.0126485048308 | 0.375 | EP300 CCNA1 CCNA2 | Regulation of TP53 Activity |
|   REAC:R-HSA-3371571 | 0.0140328389809 | 0.25 | EP300 CREBBP | HSF1-dependent transactivation |
|   REAC:R-HSA-171319 | 0.0140328389809 | 0.25 | CCNA2 CCNA1 | Telomere Extension By Telomerase |
|   KEGG:04330 | 0.0144579447004 | 0.25 | EP300 CREBBP | Notch signaling pathway |
|   HP:0012304 | 0.014877056319 | 0.25 | EP300 CREBBP | Hypoplastic aortic arch |
|   HP:0010066 | 0.014877056319 | 0.25 | EP300 CREBBP | Duplication of phalanx of hallux |
|   HP:0010181 | 0.014877056319 | 0.25 | EP300 CREBBP | Duplication of phalanx of toe |
|   REAC:R-HSA-69273 | 0.0166306183768 | 0.25 | CCNA2 CCNA1 | Cyclin A/B1/B2 associated events during G2/M transition |
|   REAC:R-HSA-186712 | 0.0166306183768 | 0.25 | EP300 CREBBP | Regulation of beta-cell development |
|   REAC:R-HSA-212436 | 0.0167421784996 | 0.625 | CCNA1 EP300 CREBBP CCNA2 SKP2 | Generic Transcription Pathway |
|   REAC:R-HSA-1538133 | 0.0180115696713 | 0.25 | CCNA2 CCNA1 | G0 and Early G1 |
|   KEGG:04720 | 0.0183114668239 | 0.25 | EP300 CREBBP | Long-term potentiation |
|   HP:0004209 | 0.0189093119923 | 0.5 | EP300 SCAPER CREBBP CDT1 | Clinodactyly of the 5th finger |
|   HP:0009179 | 0.0191205429903 | 0.5 | EP300 SCAPER CREBBP CDT1 | Deviation of the 5th finger |
|   REAC:R-HSA-69205 | 0.0194471683576 | 0.25 | CDT1 CCNA1 | G1/S-Specific Transcription |
|   REAC:R-HSA-5689880 | 0.0202356635663 | 0.375 | SKP2 CCNA1 CCNA2 | Ub-specific processing proteases |
|   KEGG:03250 | 0.0204060704272 | 0.25 | EP300 CREBBP | Viral life cycle - HIV-1 |
|   HP:0009937 | 0.020501074829 | 0.25 | EP300 CREBBP | Facial hirsutism |
|   WP:WP560 | 0.021360968316 | 0.25 | EP300 CREBBP | TGF beta receptor signaling |
|   KEGG:05221 | 0.021864446587 | 0.25 | CCNA2 CCNA1 | Acute myeloid leukemia |
|   REAC:R-HSA-9711123 | 0.0219710844704 | 0.375 | EP300 CREBBP SKP2 | Cellular response to chemical stress |
|   REAC:R-HSA-933541 | 0.0224821270291 | 0.25 | EP300 CREBBP | TRAF6 mediated IRF7 activation |
|   HP:0000327 | 0.0228486544917 | 0.375 | EP300 CREBBP CDT1 | Hypoplasia of the maxilla |
|   WP:WP4816 | 0.0234061736065 | 0.25 | EP300 CREBBP | TGF beta receptor signaling in skeletal dysplasias |
|   HP:0012842 | 0.0236486099347 | 0.25 | EP300 CREBBP | Skin appendage neoplasm |
|   REAC:R-HSA-69275 | 0.0241789966573 | 0.375 | EP300 CCNA1 CCNA2 | G2/M Transition |
|   REAC:R-HSA-453274 | 0.0249460207152 | 0.375 | EP300 CCNA1 CCNA2 | Mitotic G2-G2/M phases |
|   HP:0040019 | 0.0252507257231 | 0.5 | EP300 SCAPER CREBBP CDT1 | Finger clinodactyly |
|   KEGG:05211 | 0.0265361384039 | 0.25 | EP300 CREBBP | Renal cell carcinoma |
|   HP:0000678 | 0.0265738611142 | 0.375 | EP300 SCAPER CREBBP | Dental crowding |
|   HP:0001869 | 0.0270195830756 | 0.25 | EP300 CREBBP | Deep plantar creases |
|   HP:0002699 | 0.0270195830756 | 0.25 | EP300 CREBBP | Abnormal foramen magnum morphology |
|   HP:0000559 | 0.0270195830756 | 0.25 | EP300 CREBBP | Corneal scarring |
|   REAC:R-HSA-73857 | 0.0284039231402 | 0.625 | CCNA1 EP300 CREBBP CCNA2 SKP2 | RNA Polymerase II Transcription |
|   REAC:R-HSA-8864260 | 0.02920582473 | 0.25 | EP300 CREBBP | Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors |
|   HP:0009889 | 0.0306138099712 | 0.25 | EP300 CREBBP | Localized hirsutism |
|   HP:0000387 | 0.0306138099712 | 0.25 | EP300 CREBBP | Absent earlobe |
|   HP:0002869 | 0.0306138099712 | 0.25 | EP300 CREBBP | Flared iliac wing |
|   HP:0006349 | 0.0306138099712 | 0.25 | EP300 CREBBP | Agenesis of permanent teeth |
|   REAC:R-HSA-6804757 | 0.0328938418336 | 0.25 | CCNA2 CCNA1 | Regulation of TP53 Degradation |
|   HP:0010059 | 0.0344311064357 | 0.25 | EP300 CREBBP | Broad hallux phalanx |
|   REAC:R-HSA-6806003 | 0.0348192347107 | 0.25 | CCNA2 CCNA1 | Regulation of TP53 Expression and Degradation |
|   HP:0000326 | 0.0367737328953 | 0.375 | EP300 CREBBP CDT1 | Abnormal maxilla morphology |
|   HP:0002099 | 0.0367737328953 | 0.375 | EP300 SCAPER CREBBP | Asthma |
|   REAC:R-HSA-9758941 | 0.0367988237757 | 0.25 | EP300 CREBBP | Gastrulation |
|   HP:0002866 | 0.0384712883781 | 0.25 | EP300 CREBBP | Hypoplastic iliac wing |
|   HP:0011682 | 0.0384712883781 | 0.25 | EP300 CREBBP | Perimembranous ventricular septal defect |
|   REAC:R-HSA-3899300 | 0.0388325640363 | 0.25 | EP300 CREBBP | SUMOylation of transcription cofactors |
|   WP:WP3651 | 0.0389422604329 | 0.25 | EP300 CREBBP | Pathways affected in adenoid cystic carcinoma |
|   GO:0097124 | 0.0393180950424 | 0.25 | CCNA2 CCNA1 | cyclin A2-CDK2 complex |
|   WP:WP5158 | 0.0402976114103 | 0.25 | EP300 CREBBP | Urotensin II mediated signaling pathway |
|   WP:WP5293 | 0.0402976114103 | 0.25 | CCNA2 CCNA1 | Acute myeloid leukemia |
|   REAC:R-HSA-597592 | 0.0405127359976 | 0.625 | CCNA1 EP300 CREBBP CCNA2 SKP2 | Post-translational protein modification |
|   REAC:R-HSA-9012852 | 0.0409204105231 | 0.25 | EP300 CREBBP | Signaling by NOTCH3 |
|   HP:0002705 | 0.0409601936324 | 0.375 | EP300 CREBBP CDT1 | High, narrow palate |
|   KEGG:03083 | 0.0411542607239 | 0.25 | EP300 CREBBP | Polycomb repressive complex |
|   HP:0004207 | 0.0420951818936 | 0.5 | EP300 SCAPER CREBBP CDT1 | Abnormal 5th finger morphology |
|   KEGG:04914 | 0.0421715550792 | 0.25 | CCNA2 CCNA1 | Progesterone-mediated oocyte maturation |
|   HP:0020206 | 0.0427341718023 | 0.25 | EP300 CREBBP | Simple ear |
|   REAC:R-HSA-2122947 | 0.04306231829 | 0.25 | EP300 CREBBP | NOTCH1 Intracellular Domain Regulates Transcription |
|   WP:WP1403 | 0.0430766937311 | 0.25 | CCNA2 CCNA1 | AMP activated protein kinase signaling |
|   KEGG:04916 | 0.0432009834453 | 0.25 | EP300 CREBBP | Melanogenesis |
|   KEGG:04520 | 0.0463619704146 | 0.25 | EP300 CREBBP | Adherens junction |
|   HP:0000419 | 0.0472195728067 | 0.25 | EP300 CREBBP | Abnormal nasal septum morphology |
|   HP:0000049 | 0.0472195728067 | 0.25 | EP300 CREBBP | Shawl scrotum |
|   HP:0009836 | 0.0472195728067 | 0.25 | EP300 CREBBP | Broad distal phalanx of finger |
|   HP:0002236 | 0.0472195728067 | 0.25 | EP300 CREBBP | Frontal upsweep of hair |
|   KEGG:04350 | 0.0474398326563 | 0.25 | EP300 CREBBP | TGF-beta signaling pathway |
|   REAC:R-HSA-9707616 | 0.0475081379956 | 0.25 | EP300 CREBBP | Heme signaling |
|   HP:0004097 | 0.0480842911934 | 0.5 | EP300 SCAPER CREBBP CDT1 | Deviation of finger |
|   CORUM:5320 | 0.0499436884912 | 0.125 | SKP2 | CDH1-SKP2 complex |
|   CORUM:5556 | 0.0499436884912 | 0.125 | CCNA2 | CDK2-CCNA2 complex |
|   CORUM:5198 | 0.0499436884912 | 0.125 | CREBBP | CBP-RARA-RXRA-DNA complex, ligand stimulated |
Edges
| Protein 1 | Protein 2 | Score | ProteomeHD | Interface Overlap | Evidence |
|---|---|---|---|---|---|
|  SKP2 |  CCNA2 | 1.0 | 0.284           |
mutually_exclusive (P11802)        
structurally_consistent (dimer)         |
hein_WMM     bioplex3_HEK293     bioplex ()     bioplex_WMM     bioplex3_WMM     hein ()     bioplex3_HCT116     |
|  CDT1 |  CCNA2 | 1.0 | 0.128           |          | hein_WMM     bioplex3_HEK293     bioplex ()     bioplex_WMM     bioplex3_WMM     hein ()     bioplex3_HCT116     |
|  SCAPER |  CCNA2 | 0.999 | 0.176           |
structurally_consistent (dimer)        
|
hein_WMM     bioplex3_HEK293     bioplex ()     bioplex_WMM     bioplex3_WMM     hein ()     bioplex3_HCT116     |
|  CKS2 |  CCNA2 | 0.999 | 0.206           |
structurally_consistent (dimer)        
|
hein_WMM     bioplex3_HEK293     bioplex ()     bioplex_WMM     bioplex3_WMM     bioplex3_HCT116     |
|  EP300 |  CREBBP | 0.999 | 0.476           |          | bioplex_WMM     bioplex3_WMM     boldt     youn_WMM     fraction     boldt_WMM     |
|  CKS2 |  SKP2 | 0.998 | 0.098           |          | hein_WMM     bioplex_WMM     bioplex3_WMM     WMM_only     |
|  SKP2 |  CDT1 | 0.998 | 0.21           |          | hein_WMM     bioplex_WMM     bioplex3_WMM     hein ()     |
|  CREBBP |  CCNA2 | 0.996 | 0.236473684211           |          | bioplex3_HEK293     bioplex ()     bioplex_WMM     bioplex3_WMM     boldt     boldt_WMM     |
|  EP300 |  CCNA2 | 0.995 | 0.266809384164           |          | bioplex3_HEK293     bioplex ()     bioplex_WMM     bioplex3_WMM     boldt     boldt_WMM     |
|  MIDEAS |  CCNA2 | 0.995 | 0.06           |          | hein_WMM     bioplex3_HEK293     bioplex ()     bioplex_WMM     bioplex3_WMM     hein ()     |
|  CCNA2 |  CCNA1 | 0.993 |            |
structurally_consistent (dimer)        
|
bioplex3_HEK293     bioplex ()     bioplex_WMM     bioplex3_WMM     |
|  MIDEAS |  SKP2 | 0.937 | 0.056           |          | hein_WMM     bioplex_WMM     bioplex3_WMM     youn_WMM     WMM_only     |
|  CKS2 |  CDT1 | 0.93 | 0.088           |
mutually_exclusive (P06493)        
|
bioplex3_HEK293     bioplex ()     bioplex_WMM     bioplex3_WMM     |
|  CDT1 |  SCAPER | 0.809 | 0.178           |          | hein_WMM     bioplex_WMM     bioplex3_WMM     WMM_only     |
|  SKP2 |  SCAPER | 0.788 | 0.154           |          | hein_WMM     bioplex_WMM     bioplex3_WMM     WMM_only     |
|  MIDEAS |  SCAPER | 0.774 | 0.076           |          | hein_WMM     bioplex_WMM     bioplex3_WMM     youn_WMM     WMM_only     |
|  CKS2 |  MIDEAS | 0.749 | 0.012           |          | hein_WMM     bioplex_WMM     bioplex3_WMM     youn_WMM     WMM_only     |
|  CKS2 |  SCAPER | 0.563 | 0.032           |          | bioplex_WMM     bioplex3_WMM     WMM_only     |
|  MIDEAS |  CCNA1 | 0.502 |            |          | bioplex_WMM     bioplex3_WMM     WMM_only     |
|  SCAPER |  CCNA1 | 0.487 |            |          | bioplex_WMM     bioplex3_WMM     WMM_only     |
|  MIDEAS |  CDT1 | 0.396 | 0.072           |          | hein_WMM     bioplex_WMM     bioplex3_WMM     WMM_only     |
|  CDT1 |  CCNA1 | 0.35 |            |          | bioplex_WMM     bioplex3_WMM     WMM_only     |
|  CREBBP |  CCNA1 | 0.333 |            |          | bioplex_WMM     bioplex3_WMM     WMM_only     |
|  CKS2 |  CCNA1 | 0.218 |            |          | bioplex_WMM     bioplex3_WMM     WMM_only     |
|  MIDEAS |  CREBBP | 0.185 | 0.132           |          | bioplex_WMM     bioplex3_WMM     youn_WMM     WMM_only     |
|  EP300 |  MIDEAS | 0.178 | 0.258           |          | bioplex_WMM     bioplex3_WMM     youn_WMM     WMM_only     |
|  EP300 |  CCNA1 | 0.172 |            |          | bioplex_WMM     bioplex3_WMM     WMM_only     |
|  SCAPER |  CREBBP | 0.172 | 0.208           |          | bioplex_WMM     bioplex3_WMM     WMM_only     |
|  EP300 |  SCAPER | 0.164 | 0.27           |          | bioplex_WMM     bioplex3_WMM     WMM_only     |
|  EP300 |  CKS2 | 0.16 | 0.024           |          | bioplex_WMM     bioplex3_WMM     WMM_only     |
|  SKP2 |  CCNA1 | 0.156 |            |          | bioplex_WMM     bioplex3_WMM     WMM_only     |
|  CDT1 |  CREBBP | 0.143 | 0.248           |          | bioplex_WMM     bioplex3_WMM     WMM_only     |
|  EP300 |  CDT1 | 0.143 | 0.26           |          | bioplex_WMM     bioplex3_WMM     WMM_only     |
|  EP300 |  SKP2 | 0.12 | 0.280075471698           |          | bioplex_WMM     bioplex3_WMM     WMM_only     |
|  CKS2 |  CREBBP | 0.12 | 0.016           |          | bioplex_WMM     bioplex3_WMM     WMM_only     |
|  SKP2 |  CREBBP | 0.111 | 0.260784313725           |          | bioplex_WMM     bioplex3_WMM     WMM_only     |
Related Complexes